GRATTAROLA, MARGHERITA

GRATTAROLA, MARGHERITA  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism 2020 Cucci M.A.; Grattarola M.; Dianzani C.; Damia G.; Ricci F.; Roetto A.; Trotta F.; Barrera G.; Pizzimenti S.
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression 2019 Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina
Carbosilane dendrimers loaded with sirna targeting nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells 2020 Ambrosio L.; Argenziano M.; Cucci M.A.; Grattarola M.; de Graaf I.A.M.; Dianzani C.; Barrera G.; Nieves J.S.; Gomez R.; Cavalli R.; Pizzimenti S.
Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role 2021 Barrera G.; Cucci M.A.; Grattarola M.; Dianzani C.; Muzio G.; Pizzimenti S.
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications 2023 Boggio E.; Gigliotti C.L.; Stoppa I.; Pantham D.; Sacchetti S.; Rolla R.; Grattarola M.; Monge C.; Pizzimenti S.; Dianzani U.; Dianzani C.; Battaglia L.
Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle 2023 Azzimonti B.; Ballacchino C.; Zanetta P.; Cucci M.A.; Monge C.; Grattarola M.; Dianzani C.; Barrera G.; Pizzimenti S.
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities 2022 Sequera, Celia; Grattarola, Margherita; Holczbauer, Agnes; Dono, Rosanna; Pizzimenti, Stefania; Barrera, Giuseppina; Wangensteen, Kirk J; Maina, Flavio
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma 2023 Cucci M.A.; Grattarola M.; Monge C.; Roetto A.; Barrera G.; Caputo E.; Dianzani C.; Pizzimenti S.
Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma 2023 M.A.Cucci, M. Grattarola, C. Monge, A. Roetto, C. Dianzani, S.Pizzimenti
Nrf2, YAP, antioxidant potential, and cancer 2021 Giuseppina Barrera, Marie Angele Cucci, Margherita Grattarola, Stefania Pizzimenti
Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies 2021 Pizzimenti S.; Ribero S.; Cucci M.A.; Grattarola M.; Monge C.; Dianzani C.; Barrera G.; Muzio G.
Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells 2021 Grattarola M.; Cucci M.A.; Roetto A.; Dianzani C.; Barrera G.; Pizzimenti S.
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 2019 Cucci M.A.; Compagnone A.; Daga M.; Grattarola M.; Ullio C.; Roetto A.; Palmieri A.; Rosa A.C.; Argenziano M.; Cavalli R.; Simile M.M.; Pascale R.M.; Dianzani C.; Barrera G.; Pizzimenti S.
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma 2023 Foglietta, Federica; Bozza, Annalisa; Ferraris, Chiara; Cangemi, Luigi; Bordano, Valentina; Serpe, Loredana; Martina, Katia; Lazzarato, Loretta; Pizzimenti, Stefania; Grattarola, Margherita; Cucci, Marie Angele; Dianzani, Chiara; Battaglia, Luigi
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma 2022 Argenziano M.; Bessone F.; Dianzani C.; Cucci M.A.; Grattarola M.; Pizzimenti S.; Cavalli R.